Image

Male breAsT cAncer preDisposition Factor: Creation of a Control Cohort 2

Male breAsT cAncer preDisposition Factor: Creation of a Control Cohort 2

Recruiting
66 years and older
Male
Phase N/A

Powered by AI

Overview

This is an interventional, prospective, single-center study designed to collect and describe genetic, environmental and psychosocial control data from male participants. The participants did not have any prior history of cancer at the time of the oncogenetic consultation and do not have the family mutation researched during the oncogenetic consultation (targeted genetic testing). The participants are referenced in the IUCT-O medical records as family members of patients suffering from male breast cancer.

The study will be conducted on a population of 120 participants.

Eligibility

Inclusion Criteria:

  • 1\. A male volunteer participant with no personal history of cancer, registered in the IUCT-O oncogenetics database as a relative of a patient carrying a pathogenic or likely pathogenic variant in one of the cancer predisposition genes routinely analyzed at the oncogenetics laboratory
  • 2\. Age ≥ 66 years
  • 3\. Participant with no known family relationship to a patient of the MATADOR1 cohort
  • 4\. Participant who has undergone an oncogenetic consultation at the IUCT-O
  • 5\. Participant who does not carry the familial mutation in any of the cancer predisposition genes previously tested
  • 6\. Participant for which an archived blood sample is available for the research in the oncogenetics laboratory
  • 7\. Participant having signed an informed consent form before inclusion in the study and before any study specific procedure

Exclusion Criteria:

  • 1\. Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).

Study details
    Male Breast Cancer

NCT07558343

Institut Claudius Regaud

31 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.